retatrutide what is it clinical trial Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more at our link in bio VisualAbstract: Retatrutide reduces body weight

Novel pharmacological therapy in type 2 diabetes mellitus with established cardiovascular disease: Current evidence

View Catalog Growth Hormone CJC-1295, Ipamorelin, Sermorelin GHRH analogs and ghrelin mimetics

Any exposure above 8C for more than 24 hours causes irreversible aggregation that neither visual inspection nor home potency testing can detect

Oral formulations expand access for needle-averse patients: oral semaglutide is $289/mo month-to-month (or $249/mo on the 6-month plan), and oral tirzepatide from $349/mo (or $279/mo on the 6-month plan)

It's a holistic approach to enabling groundbreaking research